U.S. Markets closed

Vince Holding Corp. (VNCE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
10.460.00 (0.00%)
At close: 03:26PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close10.46
Bid6.50 x 1000
Ask10.50 x 900
Day's Range10.25 - 10.62
52 Week Range5.10 - 13.51
Avg. Volume12,611
Market Cap124.458M
Beta (5Y Monthly)2.41
PE Ratio (TTM)N/A
EPS (TTM)-2.47
Earnings DateDec 20, 2021 - Dec 27, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
  • Zacks

    Vince Holding Corp. (VNCE) Stock Jumps 8.7%: Will It Continue to Soar?

    Vince Holding Corp. (VNCE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  • Simply Wall St.

    Strong week for Vince Holding (NYSE:VNCE) shareholders doesn't alleviate pain of five-year loss

    Vince Holding Corp. ( NYSE:VNCE ) shareholders should be happy to see the share price up 20% in the last month. But...

  • Benzinga

    41 Stocks Moving In Friday's Mid-Day Session

    Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22. Echo Global Logistics, Inc. (NASDAQ: ECHO) surged 53.8% to $48.16 after the company agreed to be acquired by priva